�鶹��ý��վ News - Research and innovation

�鶹��ý��վ scientists unveil “Alenomers,” a new molecular platform that could rival antibodies

webfull — Thu, 07 May 2026 15:53:05 +0000

Montreal, May 6, 2026 – Researchers from �鶹��ý��վ have introduced a groundbreaking new class of molecules that could significantly reshape drug discovery and development. The technology, called Aptamer‑Like ENcoded OligoMERs (Alenomers), combines the advantages of antibodies and DNA‑based therapeutics while overcoming key limitations of both.

Published: 7 May 2026

�鶹��ý��վ scientists unveil “Alenomers,” a new molecular platform that could rival antibodies

webfull — Wed, 06 May 2026 13:43:31 +0000

Published: 6 May 2026

Five scholarly journals at �鶹��ý��վ receive SSHRC funding

webfull — Thu, 30 Apr 2026 14:05:35 +0000

Social Sciences and Humanities Research Council (SSHRC) awards $598,278 to five �鶹��ý��վ journals spanning disciplines from law to religion

Published: 30 April 2026

D2R awards $5.74 million in Translational Impact Research funding

webfull — Wed, 29 Apr 2026 15:49:13 +0000

Montreal – April 29, 2026 | �鶹��ý��վ’s DNA to RNA Initiative (D2R) has invested nearly $6 million in funding to support four groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on April 23-24, 2026.

Published: 29 April 2026

Social Work Professor Myriam Denov receives Governor General’s Innovation Award

webfull — Wed, 22 Apr 2026 18:09:32 +0000

Published: 22 April 2026

NSERC awards two �鶹��ý��վ professors $1.65 million each to prepare the next generation of researchers

webfull — Tue, 21 Apr 2026 16:07:07 +0000

Projects focusing on MedTech and genomics cut across disciplines while mobilizing expertise at �鶹��ý��վ and other Quebec institutions to meet the challenges of today and tomorrow

Published: 21 April 2026

EDI Workshop | EDI Missteps: Solutions, Strategies and Successful Practices

webfull — Thu, 16 Apr 2026 20:43:05 +0000

In an effort to support researchers in incorporating the principles of Equity, Diversity, and Inclusion (EDI) into their work as RNA research, the D2R EDI Community of Practice is organizing an event to discuss and problem solve through common EDI mistakes in the context of RNA research. In this event, two speakers will share anecdotes on major EDI pitfalls they have encountered and strategies others can use to prevent them in the future. Together, we will discuss common pitfalls in a collaborative and low-pressure environment.

Published: 16 April 2026

D2R x Lavery | Patenting Your Invention: A Guide for Researchers

webfull — Wed, 15 Apr 2026 17:45:43 +0000

Have an innovative idea and not sure how the patenting process works? Join D2R and Lavery to learn how patent strategy supports scientific impact and how early choices impact downstream commercialization value when bringing life science innovations to market.

Designed to be accessible without sacrificing rigor, this session equips researchers and research administrators with a clearer understanding of how patent strategy supports scientific impact - and how early choices can materially affect downstream value and commercialization to bring life sciences innovations to market.

Published: 15 April 2026

Weston Family Foundation awards two �鶹��ý��վ researchers for human microbiome research

webfull — Tue, 14 Apr 2026 15:52:06 +0000

New funding fuels �鶹��ý��վ-led breakthroughs on how gut viruses influence childhood health and how engineered proteins can prevent damaging oral bacterial biofilms.

Published: 14 April 2026

Event | Free AReNA Series of Webinars

webfull — Fri, 10 Apr 2026 14:58:53 +0000

AReNA is launching a series of free webinars dedicated to RNA therapies, spotlighting leading international companies to fuel innovation, inspire the local ecosystem, and create tangible collaboration opportunities.

The first webinar in this series focuses on one of the field’s most critical challenges: biomanufacturing.

Reinventing RNA biofabrication : fermentation, innovative vectors and new-generation delivery

Tuesday, April 24 from 8:30 to 9:30 am, three companies present disruptive biofabrication technologies.

Published: 10 April 2026